Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Revolade 50mg tablets
0901040C0BBABAB
|
Revolade | Eltrombopag | Nutrition and Blood | No data available |
|
Revolade 75mg tablets
0901040C0BBACAC
|
Revolade | Eltrombopag | Nutrition and Blood | No data available |
|
Rewisca 100mg capsules
0408010AEBCAAAD
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 200mg capsules
0408010AEBCAFAF
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 225mg capsules
0408010AEBCAGAI
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 25mg capsules
0408010AEBCABAA
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 300mg capsules
0408010AEBCAHAG
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 50mg capsules
0408010AEBCACAB
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Reyataz 100mg capsules
0503010L0BBACAC
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 150mg capsules
0503010L0BBAAAA
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 200mg capsules
0503010L0BBABAB
|
Reyataz | Atazanavir | Infections | No data available |
|
Reyataz 300mg capsules
0503010L0BBADAD
|
Reyataz | Atazanavir | Infections | No data available |
|
Rezolsta 800mg/150mg tablets
0503010AKBBAAAA
|
Rezolsta | Darunavir/cobicistat | Infections | No data available |
|
Rezurock 200mg tablets
0802040BEBBAAAA
|
Rezurock | Belumosudil | Malignant Disease and Immunosuppression | No data available |
|
Rheumacin LA 75mg capsules
1001010K0BKAAAD
|
Rheumacin LA | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Rheumatac Retard 75 tablets
1001010C0CEAAAL
|
Rheumatac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Rheumox 300mg capsules
1001010B0BBAAAA
|
Rheumox | Azapropazone | Musculoskeletal and Joint Diseases | No data available |
|
Rheumox 600mg tablets
1001010B0BBABAB
|
Rheumox | Azapropazone | Musculoskeletal and Joint Diseases | No data available |
|
Rhino-Syrup Allergy 2mg/5ml
0304010G0BHAAAP
|
Rhino-Syrup Allergy | Chlorphenamine maleate | Respiratory System | No data available |
|
Rhinocort Aqua 100micrograms/dose nasal spray
1202010I0BBACAC
|
Rhinocort | Budesonide | Ear, Nose and Oropharynx | No data available |
|
Rhophylac 1,500units/2ml inj pre-filled syringes
1405030A0BDAAAJ
|
Rhophylac | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Rhotard Morphine SR 100mg tablets
0407020Q0BPADAH
|
Rhotard | Morphine sulfate | Central Nervous System | No data available |
|
Rhotard Morphine SR 10mg tablets
0407020Q0BPAAAK
|
Rhotard | Morphine sulfate | Central Nervous System | No data available |
|
Rhotard Morphine SR 30mg tablets
0407020Q0BPABAL
|
Rhotard | Morphine sulfate | Central Nervous System | No data available |
|
Rhotard Morphine SR 60mg tablets
0407020Q0BPACAI
|
Rhotard | Morphine sulfate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.